Home › Funds › Verdad Advisers, LP › TENX

Verdad Advisers, LP position in TENX

TENAX THERAPEUTICS INC · Health Care

Verdad Advisers, LP reported holding 123,174 shares of TENX (TENAX THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.8M, representing 1.72% of its reported portfolio and ranking #6 among its reported holdings. Verdad Advisers, LP has disclosed TENX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)123.17K sh
Reported value held$1.79M
Portfolio Weight1.72%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Verdad Advisers, LP's TENX position evolved

Verdad Advisers, LP first disclosed a stake in TENX in Q1 2026 at 95,330 shares (US$1.5M). The position peaked in Q2 2026 at 123,174 shares, worth US$1.8M. Across 2 filings, Verdad Advisers, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 123,174 shares valued at US$1.8M — an increase of 27,844 shares quarter over quarter.. Notable position changes include a 29% increase in Q2 2026 (shares fell 87% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 95.33K $1.52M New
Q2 2026 123.17K $1.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TENX and 13F data

TENX (TENAX THERAPEUTICS INC) is a Health Care company. 103 other funds we track also report a position in TENX — the largest reported positions include Vivo Capital, LLC (US$36.4M), Stonepine Capital Management, LLC (US$9.6M), Sofinnova Investments, Inc. (US$7.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TENX

All TENX fund holders →

FAQ

How long has Verdad Advisers, LP held TENX?

Verdad Advisers, LP has disclosed TENX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Verdad Advisers, LP's current position in TENX?

As of Q2 2026, Verdad Advisers, LP holds 123.17K shares of TENX (TENAX THERAPEUTICS INC), valued at $1.79M, representing 1.72% of its reported portfolio and ranking #6.

Has Verdad Advisers, LP been buying or selling TENX?

In the latest 13F filing (Q2 2026), Verdad Advisers, LP increased its position in TENX. The position peaked in Q2 2026 at 123.17K shares.

Which other funds hold TENX?

Other major institutional holders of TENX include Vivo Capital, LLC, Stonepine Capital Management, LLC, Sofinnova Investments, Inc., among 103 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.